(TAK) Takeda Pharmaceutical - Performance 18.9% in 12m
TAK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
6.65%
#55 in Peer-Group
Rel. Strength
66.15%
#2515 in Stock-Universe
Total Return 12m
18.88%
#44 in Peer-Group
Total Return 5y
0.92%
#64 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 65.5 |
| P/E Forward | 14.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 15.39 USD |
| 52 Week Low | 12.61 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 72.46 |
| Buy/Sell Signal +-5 | -0.70 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TAK (18.9%) vs XLV (-6%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-5.69% | 124% | 337% | 64.3 | 57.8 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
7.32% | -14.6% | 405% | 63.3 | 35.6 | 1.19 | 58.2% | 18.9% |
| NVS NYSE Novartis |
6.6% | 16.7% | 77.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
2.29% | 3% | 48.6% | 18.4 | 13.9 | 1.36 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-3.55% | 4.95% | 48.8% | 18.6 | 8.61 | 0.38 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.76% | -5.21% | 112% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.44% | -8.57% | 48.1% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.55% | -9.51% | 43.2% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: TAK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TAK
| Total Return (including Dividends) | TAK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 2.03% | 1.67% | 4.52% |
| 3 Months | 1.55% | -7.84% | 10.25% |
| 12 Months | 18.88% | -6.02% | 14.16% |
| 5 Years | 0.92% | 47.32% | 116.91% |
| Trend Score (consistency of price movement) | TAK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 3.1% | 41.7% | 79.1% |
| 3 Months | 18.4% | -51% | 91.7% |
| 12 Months | 53.5% | -70.9% | 44% |
| 5 Years | -14.9% | 88% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th58.55 | 0.35% | -2.39% |
| 3 Month | %th50.26 | 10.18% | -7.90% |
| 12 Month | %th77.72 | 26.49% | 4.13% |
| 5 Years | %th66.32 | -31.50% | -53.48% |
FAQs
Does Takeda Pharmaceutical (TAK) outperform the market?
Yes,
over the last 12 months TAK made 18.88%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.02%.
Over the last 3 months TAK made 1.55%, while XLV made -7.84%.
Performance Comparison TAK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TAK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.1% | -2.5% | 9.5% | 5% |
| US NASDAQ 100 | QQQ | -0.5% | -3.5% | 8.1% | 5% |
| German DAX 40 | DAX | -0.7% | 1.7% | -5.7% | -12% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.8% | -0.5% | 13.5% | 2% |
| Hongkong Hang Seng | HSI | -0.2% | -4.8% | -7.7% | -17% |
| India NIFTY 50 | INDA | -0.3% | -0.3% | 8.6% | 19% |
| Brasil Bovespa | EWZ | 0.8% | -1.5% | -12.1% | 8% |
TAK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.1% | -4.9% | 3.2% | -9% |
| Consumer Discretionary | XLY | 0.6% | 0.1% | 17.5% | -2% |
| Consumer Staples | XLP | 3.6% | 3.3% | 10.6% | 10% |
| Energy | XLE | 3.4% | -2.5% | 12.1% | 22% |
| Financial | XLF | 0.4% | -0.5% | 6.3% | -9% |
| Health Care | XLV | 1.2% | 0.4% | 16.2% | 25% |
| Industrial | XLI | 0.5% | -1.1% | 2.7% | -5% |
| Materials | XLB | 1.5% | -0.3% | 8.7% | 16% |
| Real Estate | XLRE | 4.8% | 2.5% | 11.2% | 7% |
| Technology | XLK | -0.7% | -6.4% | 7.3% | 8% |
| Utilities | XLU | 2.5% | 1% | 5.8% | -5% |
| Aerospace & Defense | XAR | -1.8% | -7.6% | -11.6% | -33% |
| Biotech | XBI | 1.7% | -1.2% | 22.3% | 30% |
| Homebuilder | XHB | 1.5% | -1.9% | 20% | 18% |
| Retail | XRT | 2.4% | -0.1% | 16.9% | 12% |
TAK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.7% | -7.03% | 16.7% | 29% |
| Natural Gas | UNG | 4.4% | -1.4% | 22.9% | 19% |
| Gold | GLD | 5.8% | 3.5% | -10.5% | -21% |
| Silver | SLV | 3.6% | -5.6% | -8.8% | -3% |
| Copper | CPER | -0.8% | -6.6% | -8.9% | 4% |
TAK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.9% | 0.2% | 13.3% | 18% |
| iShares High Yield Corp. Bond | HYG | 2.1% | 0.5% | 10% | 8% |